Parathyroid Hyperplasia: Clinical Trials

5 trials for Parathyroid Hyperplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown, 1 withdrawn. 2 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Withdrawn 1
Phase 31Completed 1
Phase 41Completed 1

Follow Parathyroid Hyperplasia: new trials by email Literature Review of Parathyroid Hyperplasia trials Research Report on Parathyroid Hyperplasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
NIRAF Detection Technology - Parathyroid Adenoma, Parathyroid Neoplasms
Not applicableCompletedVanderbilt-Ingram Cancer Center1602020-03-132024-05-13
Minimizing Narcotic Analgesics After Endocrine Surgery
Acetaminophen 500Mg Cap, Tylenol #3 Oral Tablet, Tramadol - Thyroid Cancer, Thyroid Nodule
Phase 4CompletedMinerva A Romero Arenas1262018-03-092021-05-11
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Cinacalcet 30 mg Tablet, Denosumab Inj 60 mg/ml, Placebo tablets - Primary Hyperparathyroidism, Parathyroid Adenoma
Phase 3CompletedPeter Vestergaard462017-03-012021-05-25
"Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"
Parathyroid Hyperplasia
UnknownSB Istanbul Education and Research Hospital1252015-12-012015-12-21
Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism
Ultrasonic ablation device - Secondary Hyperparathyroidism, End Stage Renal Disease
Not applicableWithdrawnTheraclion2011-08-012014-05-06

Narrower conditions

Parathyroid Neoplasms (3)  ·  Hyperparathyroidism, Primary (2)  ·  Agnosia (1)  ·  Goiter (1)  ·  Hypercalcemia (1)  ·  Hyperparathyroidism, Secondary (1)  ·  Kidney Failure, Chronic (1)  ·  Opioid-Related Disorders (1)  ·  Parathyroid Diseases (1)  ·  Thyroid Diseases (1)  ·  Thyroid Neoplasms (1)  ·  Thyroid Nodule (1)

Broader conditions

Endocrine System Diseases (4)  ·  Endocrine Gland Neoplasms (3)  ·  Head and Neck Neoplasms (3)  ·  Hyperparathyroidism (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Parathyroid Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Calcium Metabolism Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)

Interventions

Acetaminophen (1)  ·  Capsules (1)  ·  Cinacalcet (1)  ·  Denosumab (1)  ·  Sodium Chloride (1)  ·  Tablets (1)  ·  Tramadol (1)  ·  acetaminophen, codeine drug combination (1)

Sponsors

Minerva A Romero Arenas (1)  ·  Peter Vestergaard (1)  ·  SB Istanbul Education and Research Hospital (1)  ·  Theraclion (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (2)  ·  Denmark (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Carmen C Solorzano, MD, FACS (1)  ·  Erhan Aysan, MD (1)  ·  Henry A Reinhart, MD (1)  ·  Julius Simoni Leere, MD (1)  ·  Minerva A Romero Arenas, MD, MPH (1)  ·  Peter Vestergaard, DMSc (1)  ·  Samuel K Snyder, MD (1)

Results publications

PMID 32333877, PMID 40668552

NIH funding

2016 (1), R01CA212147 (1)